Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombocytopenia Related to Chronic Liver Disease”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT00914927
What this trial is testing

Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

Who this might be right for
Thrombocytopenia Related to Chronic Liver Disease
Eisai Inc. 130
Large-scale testing (Phase 3)Study completedNCT00516321
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 687
Large-scale testing (Phase 3)Ended earlyNCT00678587
What this trial is testing

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Who this might be right for
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCV+8 more
GlaxoSmithKline 292
Large-scale testing (Phase 3)Study completedNCT00529568
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 759
Testing effectiveness (Phase 2)Study completedNCT00110799
What this trial is testing

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis CThrombocytopenia
GlaxoSmithKline 75
Post-approval studies (Phase 4)Study completedNCT07791940
What this trial is testing

Effect of Rifaximin on Thrombocytopenia in Patients With HCV-Related Liver Cirrhosis

Who this might be right for
Thrombocytopenia Related to Chronic Liver Disease
Fayoum University Hospital 200
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000